Lindsey Rolfe
CIK 1650504 · See Remarks · last filed 2026-01-09
Lindsey Rolfe is a corporate insider who has filed 64 SEC Form 4 insider transactions across 3 companies since 2015. The most recent filing, for PBAXW, was dated Jan 9, 2026. Across all open-market trades the lifetime net is −$1.3M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
64
-$1.35M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CERO THERAPEUTICS HOLDINGS, INC. (PBAXW) Delisted | Director | — | $0.05 | — | $0 | 6 | 2026-01-09 |
| Atreca, Inc. (BCEL) Delisted | Director | — | $0.15 | — | $0 | 5 | 2023-06-15 |
| Clovis Oncology, Inc. (CLVS) Delisted | See Remarks | 113,327 | $0.08 | $9.2K | -$1.35M | 53 | 2022-11-03 |
Recent Filings
64 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-09 | CERO THERAPEUTICS HOLDINGS, INC. (PBAXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-06-02 | CERO THERAPEUTICS HOLDINGS, INC. (PBAXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-03-06 | CERO THERAPEUTICS HOLDINGS, INC. (PBAXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-02-26 | CERO THERAPEUTICS HOLDINGS, INC. (PBAXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-12-04 | CERO THERAPEUTICS HOLDINGS, INC. (PBAXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-03-27 | CERO THERAPEUTICS HOLDINGS, INC. (PBAXW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-15 | Atreca, Inc. (BCEL) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-11-03 | Clovis Oncology, Inc. (CLVS) Delisted | Mixed | +4,113 | -$4.2K | EDGAR |
| 2022-09-06 | Clovis Oncology, Inc. (CLVS) Delisted | Mixed | +2,518 | -$3.1K | EDGAR |
| 2022-08-03 | Clovis Oncology, Inc. (CLVS) Delisted | Mixed | +4,044 | -$6.3K | EDGAR |